Publications
260
Citations
11,678
Est. group size
—
Recurring co-author estimate
Active years
34
Publishing since 1993
Deanna L. Kroetz studies how genetic variation affects drug transport and metabolism, particularly for cancer chemotherapies, and how this influences drug side effects like nerve damage (neuropathy) and treatment outcomes. Her work combines genetic studies, laboratory models using stem-cell-derived neurons, and structural biology of drug transport proteins, along with precision medicine clinical trials that use genomic information to guide cancer treatment choices.
Publication output has fluctuated over the last decade, with a large spike in 2023 followed by a return to a more moderate, steady output in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma
Clinical Cancer Research · 2026
- Abstract A043: Genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma
Cancer Research · 2026
- Supplementary Tables S1-S10 from A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma
2026
- Data from A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma
2026
- Supplementary Item S1 from A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma
2026
- ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia
UNC Libraries · 2025
- Association of <scp> <i>SULT2A1</i> </scp> Locus With Abiraterone Clearance in the Alliance <scp>A031201</scp> : Randomized Phase <scp>III</scp> Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration‐Resistant Prostate Cancer
Clinical and Translational Science · 2025
- Structural basis of prostaglandin efflux by MRP4
Nature Structural & Molecular Biology · 2024
- Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons
Neuropharmacology · 2024
- Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters
Pharmaceutics · 2024
- The structural basis of prostaglandin efflux by MRP4
Biophysical Journal · 2024
- CTNI-49. PRECISION MEDICINE CLINICAL TRIAL FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA
Neuro-Oncology · 2024
- Inhibition of muscarinic receptor signaling protects human enteric inhibitory neurons against platin chemotherapy toxicity
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Paclitaxel- and vincristine-induced neurotoxicity and drug transport in sensory neurons
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Supplementary Tables 1 - 3, Figures 1 - 8 from A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
2023
- Clinical Pharmacology & Therapeutics×7
- Clinical and Translational Science×6
- UNC Libraries×6
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Clinical Cancer Research×3
- Alex Sparreboom
Medicine · The Ohio State University
- Ming Hu
Medicine · The Ohio State University
- David R. Foster
Medicine · Purdue University West Lafayette
- K. Sandy Pang
Medicine · Purdue University West Lafayette
- Christine A. Hrycyna
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile